This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Reduction of Hypertrophic Skin Scarring
and you are
between 18 and 55
years old
Phase
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The study will compare how well PF-06473871 works versus placebo in reducing skin scarring after scar revision surgery of existing breast scars. The study will also evaluate the safety of PF-06473871 in healthy adult subjects.

Provided treatments

  • Drug: PF-06473871
  • Drug: PF-06473871
Tris trial is registered with FDA with number: NCT01730339. The sponsor of the trial is Pfizer and it is looking for 103 volunteers for the current phase.
Official trial title:
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring